NCT03131726View on ClinicalTrials.gov

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

January 26, 2027

Study Completion Date

March 30, 2028

Conditions
Graves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy
Interventions
DRUG

Simvastatin 40mg

see arm description

Trial Locations (1)

Unknown

RECRUITING

Dpt. of Endocrinology, SUS Malmö, Malmo

All Listed Sponsors
collaborator

Region Skane

OTHER

lead

Lund University

OTHER